Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Outcomes Following Placement of Venous Stents for Treatment of Thrombotic Venous Disease

Karen Breen, MD, Prakash Saha, Narayan Karanunithy, Beverley Hunt, Alexander Cohen, Vickie McDonald, James Uprichard, Michael Fay, MBBCHBAO, FRCPath, Stephen Black

Blood (2017) 130 (Supplement 1): 697.

https://doi.org/10.1182/blood.V130.Suppl_1.697.697

Published: 2017

Journal Articles

Distribution and Impact of Comorbidities on Survival and Leukemic Transformation in Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF)

Justyna Bartoszko, MD, Tony Panzarella, BSc MSc, Caroline Jane McNamara, MBBS, Anthea Lau, Aaron D. Schimmer, MD PhD, Andre C. Schuh, MD FRCPC, Hassan Sibai, MD, Karen W.L. Yee, MD, Mark D. Minden, MD PhD, Rebecca Devlin, PhD, Vikas Gupta, MD

Blood (2016) 128 (22): 4264.

https://doi.org/10.1182/blood.V128.22.4264.4264

Published: 2016

Journal Articles

Rivaroxaban As Treatment for Thromboembolic Venous Disease in Patients with Cancer or Neoplastic Hematology

Gregorio Campos-Cabrera, MD, Jose-Luis Campos-Villagomez, MD, Salvador Campos-Cabrera, MD, Virginia Campos-Cabrera, QFB EBC

Blood (2016) 128 (22): 5008.

https://doi.org/10.1182/blood.V128.22.5008.5008

Published: 2016

Journal Articles

Comparison of the Villalta Post Thrombotic Syndrome (PTS) Score in the Ipsilateral Versus Contralateral Leg After a First Unprovoked Deep Vein Thrombosis (DVT): Results From the REVERSE Study

Jean-Philippe Galanaud, Susan R. Kahn, MD, MSc, Michael Kovacs, Christina Holcroft, Marisol Betancourt, Philip S Wells, David Anderson, Isabelle Chagnon, MD, Gregoire Le Gal, MD, PhD, Susan Solymoss, MD, Mark A. Crowther, MD, FRCPC, Arnaud Perrier, Richard H. White, MD, Linda M Vickars, MD, FRCP(C), Tim Ramsay, Marc Rodger, MD, FRCPC

Blood (2011) 118 (21): 1236.

https://doi.org/10.1182/blood.V118.21.1236.1236

Published: 2011

Journal Articles

Rivaroxaban Compared with Enoxaparin for the Prevention of Venous Thromboembolism In Acutely Ill Medical Patients: MAGELLAN Study Methodology

Alexander Thomas Cohen, Theodore Erich Spiro, Harry Roger Büller, Lloyd Haskell, Da-Yi Hu, Russell Hull, Alexandre Mebazaa, Geno Merli, Sebastian Schellong, Alexander Spyropoulos, Victor Tapson

Blood (2010) 116 (21): 3331.

https://doi.org/10.1182/blood.V116.21.3331.3331

Published: 2010

Journal Articles

Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension Is Associated with Sustained ADAMTS13 Deficiency.

Ian J Mackie, PhD, FRCPath, Chundamannil E Eapen, MD, Neil Desley, MD, Elwyn Elias, MD, BSc, FRCP

Blood (2008) 112 (11): 2296.

https://doi.org/10.1182/blood.V112.11.2296.2296

Published: 2008

Journal Articles

Prevalence of Thrombophilia Genes in Patients with Idiopathic Thromboembolic Disease.

Eudokia Mandala, PhD, Christos Lafaras, PhD, Theodoros Dardavesis, PhD, Mattheos Speletas, PhD, Dimitrios Platogiannis, PhD, Constantina Tsioni, MD, Eudoxia Douvleti, MD, George Ilonidis

Blood (2007) 110 (11): 1644.

https://doi.org/10.1182/blood.V110.11.1644.1644

Published: 2007

Journal Articles

Comparison of Performance of Two Clinical Scales To Diagnose the Post-Thrombotic Syndrome: Correlation with Patient-Reported Disease Burden and Valvular Reflux.

Susan R. Kahn, MD, MSc, Sylvie Desmarais, MD, Thierry Ducruet, Louise Arsenault, Jeffrey S. Ginsberg, MD, VETO Study Investigators

Blood (2005) 106 (11): 4114.

https://doi.org/10.1182/blood.V106.11.4114.4114

Published: 2005

Journal Articles

The VEINES-QOL/Sym Questionnaire Is a Valid and Reliable Measure of Quality of Life in Patients with Deep Venous Thrombosis.

Susan R. Kahn, MD MSc, Donna L. Lamping, PhD, Thierry Ducruet, MSc, Louise Arsenault, Marie Jose Miron, MD, Andre Roussin, MD, Sylvie Desmarais, MD, France Joyal, MD, Jeannine Kassis, MD, Susan Solymoss, MD, Louis Desjardins, MD

Blood (2004) 104 (11): 2208.

https://doi.org/10.1182/blood.V104.11.2208.2208

Published: 2004

NARROW

Outcomes Following Placement of Venous Stents for Treatment of Thrombotic Venous Disease

Distribution and Impact of Comorbidities on Survival and Leukemic Transformation in Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF)

Rivaroxaban As Treatment for Thromboembolic Venous Disease in Patients with Cancer or Neoplastic Hematology

Comparison of the Villalta Post Thrombotic Syndrome (PTS) Score in the Ipsilateral Versus Contralateral Leg After a First Unprovoked Deep Vein Thrombosis (DVT): Results From the REVERSE Study

Rivaroxaban Compared with Enoxaparin for the Prevention of Venous Thromboembolism In Acutely Ill Medical Patients: MAGELLAN Study Methodology

Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension Is Associated with Sustained ADAMTS13 Deficiency.

Prevalence of Thrombophilia Genes in Patients with Idiopathic Thromboembolic Disease.

Comparison of Performance of Two Clinical Scales To Diagnose the Post-Thrombotic Syndrome: Correlation with Patient-Reported Disease Burden and Valvular Reflux.

The VEINES-QOL/Sym Questionnaire Is a Valid and Reliable Measure of Quality of Life in Patients with Deep Venous Thrombosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only